BIC – bacterial impedance cytometry
A novel, fast, simple, single cell approach to monitor the tiny electrical changes taking place in bacteria in response to antimicrobial agents.
Fast, adaptable, label-free, phenotypic method giving novel insights into bacterial responses.
- Antimicrobial stewardship
- Microbial diagnostics
- Antimicrobial compound/strategy
- Infection prevention
- Removal antibiotics/bacteria
- Market entry
- Marketed product
- Joint Venture
- OTHER / NA
Infectious disease area:
- North America
- South America
Companies, academics, charities, SMEs interested in an open innovation approach to antimicrobial discovery and evaluation.
UKHSA is an executive agency of the Department of Health. UKHSA Porton specialises in R&D incl. new antimicrobial therapies, vaccines & diagnostics. The AD3 (Antimicrobial Discovery, Development and Diagnostics) Group aims to develop new interventions for antimicrobial resistance (AMR) and healthcare associated infections (HCAI). The team uses a variety of approaches to develop real life solutions to practical problems and takes an interdisciplinary approach, working with a variety of groups in life sciences, chemistry, physical sciences and engineering.
Technology to support early stage evaluation of antimicrobials, including companion diagnostics. Other applications: AST for UTI, MRSA, N. gonorrhoeae; characterisation of bacteriophage infection & host susceptibility; research tool to investigate modes of action, mechanism of resistance etc. As read-out takes 30 seconds, immediate changes can be seen.